ArticleEuropean journal of endocrinology2024

Cabergoline targets multiple pathways to inhibit PRL secretion and increases stromal fibrosis.

Dongyun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.